Metastasis Prostate Adenocarcinoma: Clinical Trials

1 active not recruiting. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Active not recruiting 1

Follow Metastasis Prostate Adenocarcinoma: new trials by email Literature Review of Metastasis Prostate Adenocarcinoma trials Research Report on Metastasis Prostate Adenocarcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors Androgen Deprivation Therapy, Nivolumab, Docetaxel - Hormone Sensitive Prostate Cancer, Prostate Adenocarcinoma	Phase 2	Active not recruiting	Xiao X. Wei, MD	47	2020-05-11	2026-08-12

Interventions

Androgen Antagonists (1)  ·  Docetaxel (1)  ·  Goserelin (1)  ·  Leuprolide (1)  ·  Nivolumab (1)  ·  acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1)

Sponsors

Xiao X. Wei, MD (1)

Countries

United States (1)

Top investigators

Xiao X Wei, MD (1)